Surgical Management of Perianal Giant Condyloma Acuminatum of Buschke and Löwenstein: Case Presentation.
Buschke–Löwenstein
condyloma acuminatum
reconstructive surgery
skin surgery
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
15 Sep 2023
15 Sep 2023
Historique:
received:
22
08
2023
revised:
12
09
2023
accepted:
13
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
The Buschke-Löwenstein tumor (BLT) is an uncommon sexually transmitted ailment attributed to the human papillomavirus (HPV)-usually the 6 or 11 type (90%)-with male predominance and an overall infection rate of 0.1%. BLT or giant condyloma acuminatum is recognized as a tumor with localized aggressiveness, displaying distinctive features: the potential for destructive growth, benign histology, a rate of 56% malignant transformation, and a high rate of recurrence after surgical excision. There are several treatment choices which have been tried, including laser, cryotherapy, radiotherapy, electrocoagulation, immunotherapy, imiquimode, sincatechins, intralesional injection of 5-fluoruracil (5-FU), isolated perfusion, and local or systemic chemotherapy. In the case of an extensive tumor, preoperative chemotherapy or radiotherapy is used for tumor shrinkage, making the debulking procedure safer. HPV vaccines significantly decrease the incidence of genital warts, also decreasing the risk of BLT; HPV-6 and HPV-11 are included in these vaccines. We present a 53-year-old heterosexual man, hospitalized in our department in June 2021 with a typical cauliflower-like tumor mass involving the perianal region, which progressively increased in size for almost 7 years. The perianal mass was completely removed, ensuring negative surgical margins. The large perianal skin defect which occurred was reconstructed with fascio-cutaneous V-Y advancement flap. There was no need for protective stoma. The literature review extended from January 1980 and December 2022, utilizing Pubmed and Google Scholar as search platforms. Due to the disease's proximity to the anal verge and the limited number of reported cases, arriving at a definitive and satisfactory treatment strategy becomes challenging. The optimal approach entails thorough surgical removal of the lesion, ensuring well-defined surgical margins and performing a wide excision to minimize the likelihood of recurrence. In order to repair the large wound defects, various rotation or advancement flaps can be used, resulting in reduced recovery time and a diminished likelihood of anal stricture or other complications. Our objective is to emphasize the significance of surgical excision in addressing BLT through the presentation of a case involving a substantial perianal condyloma acuminatum, managed successfully with complete surgical removal and the utilization of a V-Y advancement flap technique. In the present case, after 5 months post operation, the patient came back with a buttock abscess, which was incised and drained. After another 5 months, the patient returned for difficult defecation, with an anal stenosis being diagnosed. An anal dilatation and sphincterotomy were carried out, with good postoperative results. The surgical management of Buschke-Löwenstein tumors needs a multidisciplinary team with specialized expertise. The reconstruction techniques involved can be challenging and may introduce additional complications. We consider aggressive surgery, which incorporates reconstructive procedures, as the standard treatment for Buschke-Löwenstein tumors. This approach aims to achieve optimal surgical outcomes and prevent any recurrence.
Identifiants
pubmed: 37763319
pii: life13091916
doi: 10.3390/life13091916
pmc: PMC10532963
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
Ann Coloproctol. 2023 Jun;39(3):204-209
pubmed: 34425047
Clin Case Rep. 2017 Feb 23;5(4):537-538
pubmed: 28396786
Dis Colon Rectum. 2015 Feb;58(2):262-3
pubmed: 25585087
Infect Dis Obstet Gynecol. 2021 Jun 30;2021:9919446
pubmed: 34305393
Infect Drug Resist. 2022 Aug 22;15:4697-4705
pubmed: 36034176
J Plast Reconstr Aesthet Surg. 2011 Nov;64(11):1533-6
pubmed: 21463975
Exp Oncol. 2019 Jun;41(2):182-184
pubmed: 31262155
Dis Colon Rectum. 2001 Dec;44(12):1878-86
pubmed: 11742180
JAAD Case Rep. 2018 Aug 15;4(7):692-694
pubmed: 30128340
Ulus Cerrahi Derg. 2015 Jul 02;31(3):170-3
pubmed: 26504423
Int J Surg Case Rep. 2013;4(12):1088-90
pubmed: 24240074
Ther Clin Risk Manag. 2022 Apr 29;18:513-522
pubmed: 35516165
GMS Interdiscip Plast Reconstr Surg DGPW. 2016 Jan 21;5:Doc07
pubmed: 26814336
Dermatol Ther. 2020 Jan;33(1):e13193
pubmed: 31837245
Int J Infect Dis. 2021 Feb;103:280-281
pubmed: 33276109
Sex Transm Dis. 2015 Oct;42(10):547-8
pubmed: 26366507
Dis Colon Rectum. 1994 Sep;37(9):950-7
pubmed: 8076499
Dermatol Ther. 2019 Jul;32(4):e12972
pubmed: 31141268
Dermatol Ther. 2019 May;32(3):e12867
pubmed: 30834614
J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1485-1491
pubmed: 29478287
J Inflamm Res. 2022 Sep 08;15:5163-5184
pubmed: 36110506
Exp Ther Med. 2021 Jan;21(1):91
pubmed: 33363602
Dis Colon Rectum. 1980 Apr;23(3):191-7
pubmed: 7379671
Chirurgia (Bucur). 2016 Sept-Oct;111(5):435-438
pubmed: 27819643
Dermatol Ther. 2020 Mar;33(2):e13268
pubmed: 32052558
Acta Dermatovenerol Croat. 2014;22(1):40-3
pubmed: 24813840
J Gastrointest Cancer. 2019 Dec;50(4):1026-1028
pubmed: 30613925
J Inflamm Res. 2022 Jun 09;15:3387-3394
pubmed: 35706527
Chirurgia (Bucur). 2020 Jan-Feb;115(1):39-49
pubmed: 32155398